Crossref
The role of immune cells in mediating the effects and prognosis of lipidome in ER+ breast cancer: A mendelian randomization study
Journal of Chinese Pharmaceutical Sciences · 30.06.2026 · 35 (6) · 560
DOI: 10.5246/jcps.2026.06.040 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Chinese Pharmaceutical Sciences, online erschienen am 10.06.2026.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). The role of immune cells in mediating the effects and prognosis of lipidome in ER+ breast cancer: A mendelian randomization study. Journal of Chinese Pharmaceutical Sciences, 35(6), 560. https://doi.org/10.5246/jcps.2026.06.040
Vancouver
The role of immune cells in mediating the effects and prognosis of lipidome in ER+ breast cancer: A mendelian randomization study. Journal of Chinese Pharmaceutical Sciences. 2026;35(6):560. doi:10.5246/jcps.2026.06.040
BibTeX
@article{euvimed2026,
title = {The role of immune cells in mediating the effects and prognosis of lipidome in ER+ breast cancer: A mendelian randomization study},
journal = {Journal of Chinese Pharmaceutical Sciences},
year = {2026},
volume = {35},
number = {6},
pages = {560},
doi = {10.5246/jcps.2026.06.040}
}
EUVIMED